A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 41,600 shares of TWST stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,600
Previous 48,300 13.87%
Holding current value
$1.77 Million
Previous $1.66 Million 23.72%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$27.95 - $53.0 $7.96 Million - $15.1 Million
-284,635 Reduced 16.62%
1,427,810 $70.4 Million
Q1 2024

May 15, 2024

SELL
$32.28 - $41.5 $4.11 Million - $5.28 Million
-127,171 Reduced 6.91%
1,712,445 $58.8 Million
Q4 2023

Feb 14, 2024

BUY
$15.08 - $38.61 $4.24 Million - $10.9 Million
281,165 Added 18.04%
1,839,616 $67.8 Million
Q3 2023

Nov 14, 2023

SELL
$18.62 - $26.57 $116,859 - $166,753
-6,276 Reduced 0.4%
1,558,451 $31.6 Million
Q2 2023

Aug 14, 2023

BUY
$11.49 - $20.46 $4.49 Million - $8 Million
390,899 Added 33.3%
1,564,727 $32 Million
Q1 2023

May 15, 2023

BUY
$14.6 - $30.9 $8.89 Million - $18.8 Million
608,802 Added 107.75%
1,173,828 $17.7 Million
Q4 2022

Feb 14, 2023

BUY
$21.92 - $39.37 $10.9 Million - $19.6 Million
497,109 Added 731.94%
565,026 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$33.44 - $56.56 $13.7 Million - $23.2 Million
-410,309 Reduced 85.8%
67,917 $2.39 Million
Q2 2022

Aug 15, 2022

BUY
$26.2 - $54.0 $7.11 Million - $14.6 Million
271,200 Added 131.0%
478,226 $16.7 Million
Q1 2022

May 16, 2022

BUY
$38.58 - $83.27 $810,411 - $1.75 Million
21,006 Added 11.29%
207,026 $10.2 Million
Q4 2021

Feb 14, 2022

BUY
$75.47 - $135.88 $7.77 Million - $14 Million
103,007 Added 124.09%
186,020 $14.4 Million
Q3 2021

Nov 15, 2021

BUY
$95.64 - $131.48 $7.52 Million - $10.3 Million
78,595 Added 1778.97%
83,013 $8.88 Million
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $42,302 - $68,188
480 Added 12.19%
4,418 $588,000
Q1 2021

May 17, 2021

SELL
$105.48 - $207.97 $36,179 - $71,333
-343 Reduced 8.01%
3,938 $488,000
Q4 2020

Feb 16, 2021

SELL
$76.64 - $167.89 $941,369 - $2.06 Million
-12,283 Reduced 74.15%
4,281 $605,000
Q3 2020

Nov 16, 2020

SELL
$45.46 - $78.79 $1.88 Million - $3.25 Million
-41,296 Reduced 71.37%
16,564 $1.26 Million
Q2 2020

Aug 14, 2020

BUY
$26.4 - $45.3 $1.53 Million - $2.62 Million
57,860 New
57,860 $2.62 Million
Q1 2020

May 15, 2020

SELL
$19.71 - $35.15 $2.89 Million - $5.16 Million
-146,802 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$21.0 - $26.48 $1.17 Million - $1.47 Million
55,525 Added 60.83%
146,802 $3.08 Million
Q3 2019

Nov 14, 2019

BUY
$23.72 - $33.99 $2.17 Million - $3.1 Million
91,277 New
91,277 $2.18 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.4B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.